当前位置:
X-MOL 学术
›
Expert Rev. Anti Infect. Ther.
›
论文详情
Our official English website, www.x-mol.net, welcomes your
feedback! (Note: you will need to create a separate account there.)
Challenges in TB regimen development: preserving evidentiary standards for regulatory decisions and policymaking.
Expert Review of Anti-infective Therapy ( IF 4.2 ) Pub Date : 2020-04-28 , DOI: 10.1080/14787210.2020.1756776 Lorenzo Guglielmetti 1, 2, 3 , Marcus Low 4, 5, 6 , Lindsay McKenna 5, 7
Expert Review of Anti-infective Therapy ( IF 4.2 ) Pub Date : 2020-04-28 , DOI: 10.1080/14787210.2020.1756776 Lorenzo Guglielmetti 1, 2, 3 , Marcus Low 4, 5, 6 , Lindsay McKenna 5, 7
Affiliation
(2020). Challenges in TB regimen development: preserving evidentiary standards for regulatory decisions and policymaking. Expert Review of Anti-infective Therapy: Vol. 18, No. 8, pp. 701-704.
中文翻译:
结核病治疗方案开发面临的挑战:保留证据标准以用于监管决策和决策。
(2020)。结核病治疗方案开发面临的挑战:保留证据标准以用于监管决策和决策。抗感染治疗专家评论:第一卷。18,第8号,第701-704页。
更新日期:2020-04-28
中文翻译:
结核病治疗方案开发面临的挑战:保留证据标准以用于监管决策和决策。
(2020)。结核病治疗方案开发面临的挑战:保留证据标准以用于监管决策和决策。抗感染治疗专家评论:第一卷。18,第8号,第701-704页。